Supplier Management with the new Medical Device Regulation EU MDR 745/2017 – Webinar – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Supplier Management with the new Medical Device Regulation EU MDR 745/2017” webinar has been added to ResearchAndMarkets.com’s offering. The new medical device regulation EU MDR 745/2017 in the European Union has a lot of new requirements. One hot topic is the focus on the supply chain and the interfaces to the EN ISO … [Read more…]

Cytisine Global Market Insights, Analysis and Forecast 2022-2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cytisine Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type” report has been added to ResearchAndMarkets.com’s offering. The report describes the global market size of Cytisine from 2017 to 2021 and its CAGR from 2017 to 2021, and also forecasts its market size to the end … [Read more…]

European Biosimilar Market Report 2022-2027: Expiration of Major Biologics Patents to Drive Market – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Biosimilar Market in Europe: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The biosimilar market in Europe reached a value of US$ 6,735 Million in 2021. Looking forward, the publisher expects the market to reach US$ 25,446 Million by 2027, exhibiting a CAGR of 22.8% … [Read more…]

Stents: Technologies and Global Markets 2022-2027: Greater Incidence of Non-Communicable/Chronic Diseases Fueling Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Stents: Technologies and Global Markets 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global market for stents is estimated to increase from $7.8 billion in 2022 to $9.7 billion by 2027, at a compound annual growth rate (CAGR) of 4.3% during the forecast period of 2022 through 2027. The global market for … [Read more…]

Global Blockchain Technology in Healthcare Market Report 2022-2027: Rising Application of Blockchain in Healthcare Claims and Billing Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Blockchain Technology in Healthcare Market” report has been added to ResearchAndMarkets.com’s offering. Blockchain technology in the healthcare market is being developed due to the growing incidence of data breaches. The development of unproductive healthcare database systems has tended to increase the demand for blockchain solutions in healthcare. Healthcare is on the verge … [Read more…]

Nutraceuticals, Carbon Capture, Lithium Metal Batteries, Self Healing Concrete and e-Skin for Health Vitals Monitoring – Key Trends and Growth Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Growth Opportunities in Nutraceuticals, Carbon Capture, Lithium Metal Batteries, Self Healing Concrete, and e-Skin for Health Vitals Monitoring” report has been added to ResearchAndMarkets.com’s offering. The report features information on the use of anti-secretory supplements to treat gastrointestinal disorders during cancer and HIV therapy. It covers innovations based on the use of biodegradable … [Read more…]

DEXLEVO Strengthens Global Reputation of GOURI at IMCAS, the World’s Largest Beauty Anti-Aging Society

SEOUL, South Korea–(BUSINESS WIRE)–DEXLEVO, an aesthetic medical device company, attended the international conference on cosmetic formation opening in Paris, IMCAS World Congress 2022 on 2022.06.03~06.05, and introduced the excellence and effectiveness of ‘GOURI’. IMCAS World Congress is one of the world’s top 3 cosmetic conferences, is an event where over 20,000 visitors from more than … [Read more…]

Sensorion Announces Approval in Australia to Initiate Proof of Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation

Australian approval follows recent trial approval by regulatory authorities in France MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces that the initiation of a Proof of Concept (POC) … [Read more…]

NeuroVasc Technologies Announces First Patient Treated in Clinical Trial to Evaluate Its Novel Stent-Retriever

IRVINE, Calif.–(BUSINESS WIRE)–NeuroVasc Technologies, Inc. today announced that the first patient has been treated in its US IDE Clinical Trial, ENVI RCT – NeuroVasc Envi™-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke. This trial will evaluate the safety and efficacy of the NeuroVasc ENVI™-SR, a stent-retriever intended for the treatment of acute ischemic … [Read more…]

Takeda’s TAKHZYRO® (lanadelumab) Demonstrated Positive Results in the Prevention of HAE Attacks in First and Only Open-Label Phase 3 Trial in Children Ages 2 to <12 Years

Children Ages 2 to <12 Experienced 94.8% Fewer Hereditary Angioedema (HAE) Attacks During Treatment with TAKHZYRO Over the 52-Week Treatment Period Compared to Baseline Late-Breaking Flash Talk Presentation of Phase 3 Data Highlights Positive, Clinically Meaningful Results in Children <6 Years, Where No Long-Term Prophylaxis Treatment (LTP) is Currently Approved Results are Consistent with the … [Read more…]